Immunomedics (IMMU) EBITDA US GAAP (year values) |
|||||||||
| FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -34.8 | -45.3 | -57.9 | -146.8 | -249.1 | -261.2 | ||
| Changes by years, y/y, % | +214% | +30% | +28% | +154% | +70% | +86.4% | |||
Immunomedics. EBITDA US GAAP, bln rub
Immunomedics. EBITDA US GAAP, changes, %
Immunomedics. EBITDA US GAAP, sum by quarters, bln rub
Immunomedics (IMMU) EBITDA US GAAP (quarter values) |
||||||||
| FY2017Q4 | FY2018Q1 | FY2018Q2 | FY2020Q1 | FY2020Q2 | LTM ? | |||
| EBITDA, bln rub | ? | -1.82 | -24.3 | -107.1 | -78.5 | -51.3 | -261.2 | |
| Changes by years, y/y, % | -92% | -58% | +108% | |||||
| Changes by quarters, q/q, % | -98% | +1 234% | +340% | -27% | -35% | |||